drug development Related News
Catalysing a New Golden Age of Antimicrobials
Martin Heidecker, CIO of AMR Action Fund outlines the need for a sustainable ecosystem of research and development for antimicrobials and how the Fund...
Groundbreaking treatment for COPD, asthma, and cystic fibrosis
Scientists have developed a revolutionary new treatment for COPD, asthma, and cystic fibrosis that mitigates the potentially deadly symptoms of the conditions.
The novel drug,...
Male contraceptive pill could be on the market soon
Scientists have potentially achieved a significant milestone towards developing a male contraceptive pill, a major advancement for birth control for men.
Pioneered by researchers at...
Study examines the effectiveness of remdesivir in a pill form for COVID-19
Scientists at the University of North Carolina at Chapel Hill are testing remdesivir in a pill form to understand how effective it is for...
Could lithium be used as a preventative treatment for dementia?
A team of UK scientists have discovered that lithium may potentially be an effective preventative treatment for dementia.
The team, comprised of specialists from the...
First-ever Creutzfeldt-Jakob disease treatment shows encouraging results
Early study results have highlighted the promising performance of the world’s first treatment for Creutzfeldt-Jakob disease, potentially a landmark step toward treating the deadly...
Life-extending injection for multiple myeloma available on the NHS
The NHS has announced that a life-extending injection for multiple myeloma, a bone marrow cancer, will be available to 350 patients per year in...
Defence Therapeutics: Accelerating the fight against cancer and infectious diseases
Defence Therapeutics outlines how it is actively looking to continue the development of its product pipeline in partnership with large pharmaceutical companies.
Defence Therapeutics, a...
Saphnelo approved in the EU for treatment for systemic lupus erythematosus
Saphnelo is a first-in-class type I interferon receptor antibody for patients with moderate to serve systemic lupus erythematosus.
Saphnelo (anifrolumab), licensed by AstraZeneca, has been...
Defence Therapeutics move closer to AccuTOXTM Phase I clinical trial
Defence Therapeutics has established an agreement with CATO SMS, who will advise on submitting the company’s clinical application to Health Canada to initiate a...
Inhaled vaccine for COVID-19 protects against variants of concern
In a groundbreaking development toward curbing the transmission of SARS-CoV-2, scientists have developed an innovative inhaled vaccine for COVID-19 that offers robust disease protection.
Pioneered...
New life-extending drug for advanced womb cancer on the NHS
A 30-minute treatment, the first of its kind for advanced womb cancer, is being rolled out for women across England.
Womb cancer affects the womb...
NHS to roll out new gene therapy for metachromatic leukodystrophy
The NHS has agreed on a deal for life-saving treatment for metachromatic leukodystrophy that will offer babies and young children the prospect of a...
Atezolizumab now available on the NHS for lung cancer patients
Thousands of lung cancer patients in England will be fast-tracked the revolutionary new drug, atezolizumab, which significantly reduces the risk of cancer returning.
The Medicines...
Zika vaccine demonstrates effectiveness at preventing the virus
A groundbreaking Zika vaccine has been proven to prevent the Zika virus effectively in preclinical animal studies.
The novel Zika vaccine was developed at the...
Big Boost for NervGen’s Phase II Clinical Trials
In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
New blood cancer gene defect can be treated with existing drugs
A blood cancer gene defect could be treated with drugs already available for cancers with similar defective genes, scientists at Queen’s University Belfast and...
Changing the lives of children with a new cystic fibrosis treatment
The National Health Service (NHS) has announced a new cystic fibrosis treatment is now available, which will benefit hundreds of children.
Patients in England were...
Drug may effectively help patients with COVID pneumonia
A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may benefit some...
NervGen: A new hope for treating spinal cord injuries
For decades, medical researchers have struggled in vain to solve the mystery of how to reverse paralysis caused by serious spinal cord injuries.
Finally, hope...